Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock, Par Value $0.0001 Per Share
-
Shares outstanding
-
23,267,064
-
Number of holders
-
130
-
Total 13F shares, excl. options
-
8,980,955
-
Shares change
-
+360,639
-
Total reported value, excl. options
-
$1,012,211,915
-
Value change
-
-$4,919,869
-
Put/Call ratio
-
19%
-
Number of buys
-
68
-
Number of sells
-
82
-
Price
-
$112.72
Institutional Holders of MADRIGAL PHARMACEUTICALS, INC. - Common Stock, Par Value $0.0001 Per Share (MDGL) as of Q4 2018
As of 31 Dec 2018 MADRIGAL PHARMACEUTICALS, INC. - Common Stock, Par Value $0.0001 Per Share (MDGL) had 130 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 8,980,955 shares of stock of the company.
Largest 10 holders included Capital Research Global Investors, BAKER BROS. ADVISORS LP, Vanguard Group Inc, HealthCor Management, L.P., STATE STREET CORP, BlackRock Inc., JPMORGAN CHASE & CO, ALLIANCEBERNSTEIN L.P., JENNISON ASSOCIATES LLC, and PRICE T ROWE ASSOCIATES INC /MD/.
This table shows 130 institutional shareholders of the security as of 31 Dec 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.